An integrative naturopathic oncology approach in metastatic malignant melanoma: two case reports - Report - MDSpire

An integrative naturopathic oncology approach in metastatic malignant melanoma: two case reports

  • By

  • Sara Izadi-Najafabadi

  • Sydney Moffatt

  • Mackenzie Neufeld

  • Gurdev Parmar

  • July 10, 2026

  • 0 min

Share

Clinical Report: A Comprehensive Naturopathic Oncology Strategy for Metastatic Malignant Melanoma

Background

Malignant melanoma is the most aggressive form of skin cancer, characterized by a high risk of metastasis and mortality. The standard treatment options include surgery, immunotherapy, and targeted therapy.

Data Highlights

No numerical data or trial data was presented in the article.

Key Findings

  • Case 1: A woman in her early 60s achieved clinical remission after multiple recurrences treated with surgery and naturopathic therapies.
  • Case 2: A 65-year-old woman with brain, liver, and lymph node metastases achieved complete remission after pursuing naturopathic therapies when conventional options were exhausted.
  • Both patients utilized therapies such as fever-range whole-body hyperthermia, intravenous pharmacologic ascorbic acid, and mistletoe therapy.
  • Imaging for both patients showed no evidence of disease following treatment.
  • These cases are presented as individual reports and do not imply broader applicability.

Clinical Implications

Further research is warranted to evaluate the safety and efficacy of these approaches.

Conclusion

The cases presented indicate that multimodal integrative naturopathic oncology care may contribute to remission in patients with metastatic melanoma. Larger clinical studies are needed to validate these findings.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review
  2. The ASCO Post, 2022 -- Highlights From the ESMO Congress 2022
  3. Frontiers in Immunology, 2026 -- Unmasking the “targetless” illusion: branched clonal evolution of TERT and KIT in acral melanoma revealed by sequential multi-site biopsies- a case report
  4. The ASCO Post, 2015 -- Surgery Plus Immunotherapy Improves Survival in Melanoma Patients With Gastrointestinal Metastases
  5. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PMC
  6. Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update - ScienceDirect
  7. Oncology (Cancer)/Hematologic Malignancies Approval Notifications | FDA
  8. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PMC
  9. Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update - ScienceDirect
  10. Oncology (Cancer)/Hematologic Malignancies Approval Notifications | FDA

Original Source(s)

Related Content